Valuation: OssDsign AB (publ)

Market Cap 449M 47.34M 41M 38.22M 35.15M 66.36M 4.5B 67.11M 176M 2.25B 178M 174M 7.46B P/E 2026 *
-8.7x
P/E 2027 * -12.4x
Enterprise Value 332M 35.01M 30.32M 28.26M 26M 49.08M 3.33B 49.62M 130M 1.67B 131M 129M 5.52B EV / Sales 2026 *
1.98x
EV / Sales 2027 * 1.62x
Free-Float
67.17%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 01/01/2026
Director of Finance/CFO 63 01/01/2020
Chief Tech/Sci/R&D Officer 47 01/01/2022
Director TitleAgeSince
Chairman 66 20/04/2016
Director/Board Member 60 01/01/2022
Director/Board Member 61 25/06/2024
Change 5-day change 1-year change 3-year change Capi.($)
-36.11%-.--% - - 46.42M
+0.32%-4.32%-11.51%+18.79% 129B
-1.20%-8.73%-16.72%-1.60% 12.69B
+0.23%+5.73%+94.11%+129.68% 10.05B
+0.24%+0.80%-42.81%-68.91% 4.69B
+0.51%-2.30%-18.54%+36.89% 2.62B
-6.31%+17.66%-31.65%-78.32% 1.85B
-2.20%-0.26%+14.06%-49.05% 1.78B
-2.15%-0.36%-30.54%-32.63% 1.68B
Average -5.19%+1.37%-5.45%-5.64% 20.53B
Weighted average by Cap. +0.06%-3.56%-6.60%+19.44%

Financials

2026 *2027 *
Net sales 168M 17.66M 15.29M 14.26M 13.11M 24.75M 1.68B 25.03M 65.75M 840M 66.32M 64.86M 2.78B 238M 25.12M 21.76M 20.28M 18.65M 35.22M 2.39B 35.61M 93.54M 1.2B 94.35M 92.27M 3.96B
Net income -51.27M -5.4M -4.68M -4.36M -4.01M -7.58M -514M -7.66M -20.12M -257M -20.3M -19.85M -851M -35.73M -3.77M -3.26M -3.04M -2.8M -5.28M -358M -5.34M -14.02M -179M -14.15M -13.83M -593M
Net Debt -117M -12.33M -10.68M -9.96M -9.16M -17.29M -1.17B -17.48M -45.92M -587M -46.32M -45.3M -1.94B -63M -6.64M -5.75M -5.36M -4.93M -9.31M -631M -9.41M -24.73M -316M -24.94M -24.39M -1.05B
Logo OssDsign AB (publ)
OssDsign AB, formerly known as Oss-Q AB is a Sweden-based orthopedic medical device company. It aims at developing implantable products that respond to clinical challenges, with focus on bone healing. Its primary focus is skull surgery. The Company uses design solutions, material compositions and manufacturing processes mainly based on proprietary bioceramic technologies. The bioceramics it uses integrate with tissues and support bone ingrowth. OssDsign AB's main product is Craniomosaic, an implant for the repair of skull defects (cranioplasty). Along with it, the Company develops bioceramic implants for facial bone augmentation. The Company's customers include neurosurgeons, craniofacial and maxillofacial surgeons.
Employees
35
Trader
Investor
-
Global
-
Quality
ESG MSCI
-